| - SMTL ID
- 4bpv.1
- Ligands
- (4R)-4-[(2-chloro-4-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl)sulfonyl]-N-{1-[(E)-iminomethyl]cyclopropyl}-1-{[1-(trifluoromethyl)cyclopropyl]carbonyl}-L-prolinamide
- Polypeptides
- CATHEPSIN S
- Oligo-state
- monomer
|
| - SMTL ID
- 4bpv.2
- Ligands
- (4R)-4-[(2-chloro-4-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl)sulfonyl]-N-{1-[(E)-iminomethyl]cyclopropyl}-1-{[1-(trifluoromethyl)cyclopropyl]carbonyl}-L-prolinamide
- Polypeptides
- CATHEPSIN S
- Oligo-state
- monomer
|
| - SMTL ID
- 4bpv.3
- Ligands
- (4R)-4-[(2-chloro-4-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl)sulfonyl]-N-{1-[(E)-iminomethyl]cyclopropyl}-1-{[1-(trifluoromethyl)cyclopropyl]carbonyl}-L-prolinamide
- Polypeptides
- CATHEPSIN S
- Oligo-state
- monomer
|
| - SMTL ID
- 4bpv.4
- Ligands
- (4R)-4-[(2-chloro-4-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl)sulfonyl]-N-{1-[(E)-iminomethyl]cyclopropyl}-1-{[1-(trifluoromethyl)cyclopropyl]carbonyl}-L-prolinamide
- Polypeptides
- CATHEPSIN S
- Oligo-state
- monomer
|
| - SMTL ID
- 4bpv.5
- Ligands
- (4R)-4-[(2-chloro-4-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl)sulfonyl]-N-{1-[(E)-iminomethyl]cyclopropyl}-1-{[1-(trifluoromethyl)cyclopropyl]carbonyl}-L-prolinamide
- Polypeptides
- CATHEPSIN S
- Oligo-state
- monomer
|
| - SMTL ID
- 4bpv.6
- Ligands
- -
- Polypeptides
- CATHEPSIN S
- Oligo-state
- monomer
|